SEC Form 4 · accession 0000878526-16-000201

NATUS MEDICAL INC · BABY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr. VP, CFO · Director

Period of report

Oct 24, 2016

Accepted (ET)

Oct 26, 2016 · 8:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000878526

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $0.001 par value per share	Oct 24, 2016	M	4,900	$22.50	A	91,351	D
Common Stock, $0.001 par value per share^F1	Oct 24, 2016	S	14,138	$41.606	D	77,213	D
Common Stock, $0.001 par value per share	Oct 25, 2016	M	9,905	$13.24	A	87,118	D
Common Stock, $0.001 par value per share^F2	Oct 25, 2016	S	16,138	$41.2166	D	70,980	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-qualified Stock Option^F3	$22.50	Oct 24, 2016	M	4,900	D	Feb 1, 2014	Jan 1, 2020	Common Stock	4,900	5,100	D
Non-qualified Stock Option	$13.24	Oct 25, 2016	M	9,905	D	Oct 9, 2013	Apr 9, 2019	Common Stock	9,905	17,595	D

F11.This transaction was executed in multiple trades a prices ranging from $41.47533 to $41.85357. The price reflected above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F21. This transaction was executed in multiple trades a prices ranging from $40.20428 to $41.85357. The price reflected above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3The option vests in 48 equal monthly installments beginning on the date of grant.